Lynne V. Abruzzo
Medical University of South Carolina
ORCID: 0000-0001-6113-7447Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Dwayne G. Tally, Lynne V. Abruzzo, Kevin R. Coombes, Zachary B. Abrams
Papers
Driven by 6 papers — median percentile 62. Top paper: “Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia”.
Ying Huang, Amy S. Ruppert, Lynne V. Abruzzo, Barbara L. Andersen, Farrukh T. Awan +14 more
Zachary A. Hing, Bonnie K. Harrington, J.M. Baumhardt, Hatice Gülçin Özer, Amy Lehman +22 more
Dwayne G. Tally, Lynne V. Abruzzo, Kevin R. Coombes, Zachary B. Abrams
Dwayne G. Tally, Lin Zhang, Caitlin E. Coombes, Philip Payne, Lynne V. Abruzzo +2 more
Dwayne G. Tally, Lynne V. Abruzzo, Kevin R. Coombes, Zachary B. Abrams
Lynne V. Abruzzo, Christopher C. Oakes, Antonio Perez-Castro